文献速递神经肿瘤功能神经外科

受体酪氨酸激酶基因扩增预测胶质瘤切除术中癫痫发作

Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping.
PubMed 文献 · J Neurosurg · 2019-03-29

该回顾性研究纳入2005-2017年间416例接受术中功能定位下胶质瘤切除的患者,其中98例(24%)发生术中癫痫。多因素分析显示MET基因扩增与术中癫痫独立相关,术前癫痫史和抗癫痫药物使用则降低风险。

要点

  • RTK基因扩增与术中癫痫风险升高相关(OR 5.47,95%CI 1.22-24.47,p=0.01)。
  • 术前癫痫史者术中癫痫风险较低(OR 0.61,95%CI 0.38-0.96,p=0.03)。
  • 术前使用抗癫痫药物者术中癫痫风险较低(OR 0.46,95%CI 0.26-0.80,p=0.01)。

核心结论

  • RTK基因扩增与胶质瘤功能定位切除术中癫痫发作存在既往未报道的关联,未来术中癫痫风险模型可能纳入遗传标准。

研究设计与样本

  • 回顾性研究,纳入2005-2017年在本机构接受术中功能定位下脑肿瘤切除的416例患者,记录IDH1/2、PIK3CA、BRAF、KRAS、AKT1、EGFR、PDGFRA、MET、MGMT及1p/19q状态。

主要发现

  • 416例中98例(24%)发生术中癫痫。
  • 术前癫痫史与术中癫痫风险降低相关(OR 0.61,95%CI 0.38-0.96,p=0.03)。
  • 术前抗癫痫药物负荷与术中癫痫风险降低相关(OR 0.46,95%CI 0.26-0.80,p=0.01)。
  • 单因素分析中RTK基因扩增是术中癫痫的阳性预测因素(OR 5.47,95%CI 1.22-24.47,p=0.01)。
  • 多因素分析(纳入RTK状态、抗癫痫药物使用及2007 WHO分级或2016 WHO分组)显示MET原癌基因扩增对术中癫痫的预测性最强(p<0.05)。

临床怎么用

  • 对于胶质瘤术中功能定位切除患者,RTK基因扩增(尤其是MET扩增)可能有助于识别术中癫痫高风险者。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intraoperative seizures during craniotomy with functional mapping is a common complication that impedes optimal tumor resection and results in significant morbidity. The relationship between genetic mutations in gliomas and the incidence of intraoperative seizures has not been well characterized. Here, the authors performed a retrospective study of patients treated at their institution over the last 12 years to determine whether molecular data can be used to predict the incidence of this complication. METHODS: The authors queried their institutional database for patients with brain tumors who underwent resection with intraoperative functional mapping between 2005 and 2017. Basic clinicopathological characteristics, including the status of the following genes, were recorded: IDH1/2, PIK3CA, BRAF, KRAS, AKT1, EGFR, PDGFRA, MET, MGMT, and 1p/19q. Relationships between gene alterations and intraoperative seizures were evaluated using chi-square and two-sample t-test univariate analysis. When considering multiple predictive factors, a logistic multivariate approach was taken. RESULTS: Overall, 416 patients met criteria for inclusion; of these patients, 98 (24%) experienced an intraoperative seizure. Patients with a history of preoperative seizure and those treated with antiepileptic drugs prior to surgery were less likely to have intraoperative seizures (history: OR 0.61 [95% CI 0.38-0.96], chi-square = 4.65, p = 0.03; AED load: OR 0.46 [95% CI 0.26-0.80], chi-square = 7.64, p = 0.01). In a univariate analysis of genetic markers, amplification of genes encoding receptor tyrosine kinases (RTKs) was specifically identified as a positive predictor of seizures (OR 5.47 [95% CI 1.22-24.47], chi-square = 5.98, p = 0.01). In multivariate analyses considering RTK status, AED use, and either 2007 WHO tumor grade or modern 2016 WHO tumor groups, the authors found that amplification of the RTK proto-oncogene, MET, was most predictive of intraoperative seizure (p < 0.05). CONCLUSIONS: This study describes a previously unreported association between genetic alterations in RTKs and the occurrence of intraoperative seizures during glioma resection with functional mapping. Future models estimating intraoperative seizure risk may be enhanced by inclusion of genetic criteria.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Choi BD, Lee DK, Yang JC, et al. Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping. J Neurosurg. 2019. PMID: 30925466. doi:10.3171/2018.12.JNS182700

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。